---
title: "Carlsmed Q2 net loss widens 55.3% to $10.51 million; revenue rises 57% to $18.9 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295006429.md"
description: "Carlsmed reported a Q2 net loss of $10.51 million, widening 55.3% year-over-year, despite revenue rising 57% to $18.9 million. Gross margin expanded to 76.8%, while operating expenses increased to $25.6 million due to higher sales and marketing costs. Surgeon user growth exceeded 60%, and the company raised its full-year revenue guidance to $74-$78 million."
datetime: "2026-08-05T20:05:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295006429.md)
  - [en](https://longbridge.com/en/news/295006429.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295006429.md)
generator: "portal-rs"
---

# Carlsmed Q2 net loss widens 55.3% to $10.51 million; revenue rises 57% to $18.9 million

-   Carlsmed posted Q2 revenue of USD 18.9 million, up 57% year over year, driven by rising aprevo procedures across lumbar and cervical. \* Net loss widened to USD 10.5 million; gross margin expanded 3.4 percentage points to 76.8%. \* Operating expenses climbed to USD 25.6 million, led by USD 11.9 million in sales and marketing spending. \* Trained surgeon users rose more than 60% year over year; aprevo cervical reached about 10% of quarterly revenue in its second full quarter. \* Full-year revenue guidance increased to USD 74 million-USD 78 million; CEO Mike Cordonnier cited a CMS reimbursement ruling effective Oct. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608051601PRIMZONEFULLFEED9804396) on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CARL.US](https://longbridge.com/en/quote/CARL.US.md)

## Related News & Research

- [CMS finalizes new Medicare DRG reimbursement codes for Carlsmed aprevo lumbar fusion procedures](https://longbridge.com/en/news/294692142.md)
- [Flowco files Form 3 for EVP Production Solutions Gareth Carl Ford](https://longbridge.com/en/news/296650484.md)
- [Carlsmed Earnings Call Highlights Growth, Rising Costs](https://longbridge.com/en/news/285292604.md)
- [Nexon expects MapleStory franchise revenue to rise about 40% y/y in Q3](https://longbridge.com/en/news/295754384.md)
- [Allgeier-related party Lantano Beteiligungen, linked to Supervisory Board member Carl Georg Dürschmidt, buys shares for EUR 259,200](https://longbridge.com/en/news/296091838.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**